Trials / Completed
CompletedNCT00148902
Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)
A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Docetaxel (Taxotere)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a safety and tolerability study of GW572016 given with docetaxel (TAXOTERE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lapatinib | lapatinib |
| DRUG | docetaxel | docetaxel |
Timeline
- Start date
- 2003-04-28
- Primary completion
- 2006-01-21
- Completion
- 2006-01-21
- First posted
- 2005-09-08
- Last updated
- 2017-12-06
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00148902. Inclusion in this directory is not an endorsement.